oral JH2-binding Tyk2 inhibitor

Ph. I in psoriasis complete

backup candidate to BMS-986165 for psoriasis

J. Med. Chem., Dec. 28, 2020

Bristol-Myers Squibb, Princeton, NJ

Chemical Structure of molecule BMS-986202 potent

Bristol Myers Squibb (BMS) oral JH2-domain binding Tyk2 kinase inhibitor


get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: